Lakefront Biotherapeutics Q3 EPS €(0.04) Beats €(0.19) Estimate, Sales €7.569M Miss €8.680M Estimate
Benzinga Newsdesk 1 hour ago
NewsEarningsEarnings BeatsEarnings Misses
Lakefront Biotherapeutics (NASDAQ:LKFT) reported quarterly losses of €(0.04) per share which beat the analyst consensus estimate of €(0.19) by 78.95 percent. This is a 98.7 percent increase over losses of €(3.07) per
Lakefront Biotherapeutics (NASDAQ:LKFT) reported quarterly losses of €(0.04) per share which beat the analyst consensus estimate of €(0.19) by 78.95 percent. This is a 98.7 percent increase over losses of €(3.07) per share from the same period last year. The company reported quarterly sales of €7.569 million which missed the analyst consensus estimate of €8.680 million by 12.80 percent. This is a 89.36 percent decrease over sales of €71.126 million the same period last year.